Novel substituted 5-arylidene-1, 3-thiazolidin-4-one analogues: Synthesis, optimization, anticancer screening and docking studies. Journal of Pharmaceutical Negative Results. Published online October 14, 2022:2378-2389. doi:10.47750/pnr.2022.13.S06.310